Email

weborders@prabadincorp.com

Call us

+1 (786)-332-3938

  • Home
  • Blog
  • Life style
  • Product Catalog
b77e8639-129a-40c6-b128-527621a55c3a (1)
FDA Roundup: February 28, 2025
Drug Test
  • February 28, 2025
AdminPrabadinBy AdminPrabadin - 3 months ago
0

The U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency.

Previous article

FDA issues class-wide labeling changes for testosterone products

Next article

FDA Drug Safety Communication: FDA cautions about using testosterone products for low testosterone due to aging; requires labeling change to inform of possible increased risk of heart attack and stroke with use

AdminPrabadin
administrator

Related Articles

Drug Test

PDUFA VIII: Fiscal Years 2028 – 2032

  • May 23, 2025
Drug Test

Public Meeting on the Reauthorization of the Prescription…

  • May 23, 2025

A “Pheraplex” Capsule Labeled as Desoxymethyltestosterone From the…

  • May 23, 2025

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

© Copyright Barta 2018. Designed and Developed by Komarca Soft